May 27, 2021 | Impetus Digital, Natalie Yeadon, Pharma, Valerie Sullivan, clinical research, clinical trials, digital pills, digital technology, etectRx, health analytics, healthcare, medications, partnerships, patient management
Valerie Sullivan, President and CEO at etectRx, dives into digital pills in healthcare and clinical research. Among many other things, we discuss how Pharma companies can benefit from the ability to confirm medication ingestions, how partnerships within the digital health ecosystem are helping to advance the field, and the future of digital pills.
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Jon Sockell, Co-founder and COO of Limbix, sits down with us in this Fireside Chat. See how Limbix is paving the way for prescription digital therapeutics and learn from their trials,…
In this session, we discussed systems change, wicked problems, and multisolving. We reviewed the transformational changes that can evolve and go beyond “cause and effect” thinking. In this dialogue, we…
Find out how Impetus Digital helped virtualize their client’s internal brand planning session
Eddie Power, Vice President of North America Medical Affairs, Hospital Business at Pfizer, discusses a range of topics, including the effects of COVID-19 on the way Medical Affairs teams work and…
Ladana Edwards, Partner at Deloitte Central Europe and Thomas de Bruyne, Consultant with Deloitte Belgium, share their thoughts on the future of education and the role of digital technologies such as virtual…
A holistic view of how to work with patients virtually
Craig Lipset, Founder and Advisor at Clinical Innovation Partners and former Head of Clinical Innovation and Venture Partner at Pfizer, discusses everything from his personal health journey to his professional accomplishments,…
